SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue slipped marginally during the December 2021 quarter. A decline of about Rs. 15880.00 millions was observed as compared to Rs. 16160.00 millions during the corresponding quarter last year.Net Profit of the company move down -38.85% to Rs. 1700.00  millions from Rs. 2780.00 millions  in the same quarter last year.Operating Profit reported a sharp decline to 4640.00 millions from 5810.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 15880.00 16160.00 -1.73 50820.00 49830.00 1.99 64510.00 61680.00 4.59
Other Income 370.00 110.00 236.36 1410.00 270.00 422.22 1180.00 2370.00 -50.21
PBIDT 4640.00 5810.00 -20.14 17630.00 17930.00 -1.67 23150.00 21540.00 7.47
Interest 570.00 870.00 -34.48 1870.00 2700.00 -30.74 3390.00 4300.00 -21.16
PBDT 4070.00 4940.00 -17.61 15760.00 15230.00 3.48 19760.00 17240.00 14.62
Depreciation 1520.00 1550.00 -1.94 4550.00 4580.00 -0.66 6100.00 6070.00 0.49
PBT 2550.00 3390.00 -24.78 11210.00 10650.00 5.26 13660.00 11170.00 22.29
TAX 850.00 610.00 39.34 3510.00 2060.00 70.39 2280.00 1780.00 28.09
Deferred Tax 400.00 10.00 3900.00 1550.00 190.00 715.79 -200.00 -140.00 42.86
PAT 1700.00 2780.00 -38.85 7700.00 8590.00 -10.36 11380.00 9390.00 21.19
Equity 846.20 846.20 0.00 846.20 846.20 0.00 846.20 846.20 0.00
PBIDTM(%) 29.22 35.95 -18.73 34.69 35.98 -3.59 35.89 34.92 2.76

Torrent Pharma Share Price

4178.85 22.50 (0.54%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×